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Abstract
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS) is increasingly used for rapid bacterial identification. Studies of Burkholderia pseudo-
mallei identification have involved small isolate numbers drawn from a restricted geographic
region. There is a need to expand the reference database and evaluate B. pseudomallei
from a wider geographic distribution that more fully captures the extensive genetic diversity
of this species. Here, we describe the evaluation of over 650 isolates. Main spectral profiles
(MSP) for 26 isolates of B. pseudomallei (N = 5) and other Burkholderia species (N = 21)
were added to the Biotyper database. MALDI-TOF MS was then performed on 581 B. pseu-
domallei, 19 B. mallei, 6 B. thailandensis and 23 isolates representing a range of other bac-
terial species. B. pseudomallei originated from northeast and east Thailand (N = 524), Laos
(N = 12), Cambodia (N = 14), Hong Kong (N = 4) and Australia (N = 27). All 581 B. pseudo-
mallei were correctly identified, with 100% sensitivity and specificity. Accurate identification
required a minimum inoculum of 5 x 107 CFU/ml, and identification could be performed on
spiked blood cultures after 24 hours of incubation. Comparison between a dendrogram con-
structed from MALDI-TOF MS main spectrum profiles and a phylogenetic tree based on
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recA gene sequencing demonstrated that MALDI-TOF MS distinguished between B. pseu-
domallei and B. mallei, while the recA tree did not. MALDI-TOF MS is an accurate method
for the identification of B. pseudomallei, and discriminates between this and other related
Burkholderia species.
Introduction
The genus Burkholderia is composed of Gram-negative species that are predominantly non-
pathogenic environmental saprophytes. A clinically important exception is Burkholderia pseu-
domallei, which causes an estimated 165,000 cases of melioidosis per year worldwide, of which
89,000 are predicted to be fatal [1]. A high proportion of reported cases occur in northeast
Thailand, where melioidosis is the second most common cause of community-acquired bac-
teremia and the third most common cause of death from infectious diseases [2]. B. pseudomal-
lei receives additional attention because of its biothreat potential [3], and because of infection
in travelers returning from endemic regions [4, 5]. In Thailand, B. pseudomallei is widely dis-
tributed in soil and environmental water [6–8] and may be found together with the closely
related B. thailandensis, which is very rarely associated with human disease [9].
Making an accurate diagnosis of melioidosis is key to patient outcome since empiric anti-
microbial therapy for sepsis does not include the first-line drugs recommended for melioidosis
(ceftazidime or a carbapenem). Diagnosis relies on bacterial isolation and identification since
clinical manifestations lack specificity. B. pseudomallei may be isolated from a range of clinical
specimen types, but half of melioidosis cases have positive blood cultures. Direct identification
of B. pseudomallei in positive blood cultures can reduce the time to diagnostic confirmation by
24 hours. This can be achieved using a rapid immunofluorescent assay (IFA), in which the
most common antibody described is a monoclonal that recognizes B. pseudomallei capsular
polysaccharide (CPS) [10]. This reagent is also used in a latex agglutination assay that can
identify B. pseudomallei directly in blood cultures, other sample types, and colonies picked
from culture media [11]. A monoclonal antibody against CPS has also been incorporated into
a lateral flow assay [12], which can detect B. pseudomallei directly in a range of clinical samples
and cultures.
The recent recognition of a B. thailandensis variant that expresses B. pseudomallei-like cap-
sular polysaccharide (Bp-like CPS) [13] has important implications for the accuracy of B. pseu-
domallei identification assays based on antibody detection of CPS, since this gives a false
positive result. The potential relevance of this has increased with the recent finding that B. thai-
landensis expressing Bp-like CPS is widely distributed in the environment in Thailand (V.
Hantrakul, personal communication). Occasional cross-reacting isolates of B. cepacia have
also been observed (D. Dance, personal communication). Methods that distinguish between B.
pseudomallei and other Burkholderia species such as B. thailandensis include arabinose assimi-
lation, more extended biochemical testing such as that incorporated in the commercial API
20NE biochemical kit (bioMe´rieux), real-time PCR, and sequencing [14–20]. Automated iden-
tification systems are available in many laboratories, although these may misidentify B. pseudo-
mallei as B. cepacia [21–24].
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS) has been increasingly introduced into diagnostic laboratories for rapid bacterial identifi-
cation. The first published study of its application to Burkholderia spp. evaluated 10 B. pseudo-
mallei and 17 B. mallei isolates and generated reference spectra data [25]. Several case reports
MALDI-TOF MS for diagnosis of melioidosis
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have since reported its use to diagnose melioidosis, including infection in returning travelers
[5, 26–29]. It has also been reported to differentiate between B. pseudomallei wild-type and sin-
gle gene mutants [30], to delineate clustering in a collection of 11 B. pseudomallei from north-
east Thailand [31], and to determine ceftazidime resistance simultaneously with B.
pseudomallei identification [32]. An inter-laboratory trial for the identification of highly patho-
genic bacteria using MALDI-TOF MS included one isolate each of B. pseudomallei and B. mal-
lei and concluded that a compilation of complete and comprehensive databases with spectra
from a broad strain collection was of paramount importance for accurate microbial identifica-
tion [33]. The largest evaluation of B. pseudomallei to date was undertaken using 66 B. pseudo-
mallei. Nearly all of these (62/66 isolates) were initially misidentified as B. thailandensis using
an existing database (DB5627), but an enhanced database subsequently identified all correctly
[34]. A limitation of this study was that most of the isolates (63/66) were from a single country
(Taiwan), the remaining 3 originating from Beijing, China.
At the time that this study was performed, representation of the 30 Burkholderia species in
the biotyper database was limited and did not include B. pseudomallei, B. ubonensis, B. oklaho-
mensis, B. humptydooensis or B. mallei. This indicates a need to expand the reference database
and potentially increase the sensitivity and specificity of the assay. Furthermore, the need
remains to undertake an evaluation of MALDI-TOF MS to identify B. pseudomallei drawn
from a wider geographic distribution, which is important because of the genetic distinctiveness
of isolates from Asia compared with Australasia and the highly plastic and variable genome,
both of which could impact on the performance of MALDI-TOF MS. Previous studies have
also lacked the inclusion of B. thailandensis expressing Bp-like CPS. The aim of this study was
to expand the MALDI-TOF MS database with Burkholderia spp. and then evaluate this tech-
nology using a large collection of B. pseudomallei together with other Burkholderia spp. includ-
ing B. thailandensis expressing Bp-like CPS. We added value to our findings by testing its
performance using blood cultures spiked with B. pseudomallei, and evaluating the similarity
between B. pseudomallei clusters arising from MALDI-TOF MS data compared with phyloge-
netic characterization based on recA sequence data.
Materials and methods
Bacterial isolates
B. pseudomallei and other Burkholderia species used in this study are detailed in Table 1. In
brief, these included 5 laboratory B. pseudomallei strains, 581 B. pseudomallei isolated from the
environment, humans or animals, 46 isolates belonging to eight other Burkholderia species,
and 23 isolates representing a range of other bacterial pathogens. B. pseudomallei were cultured
from humans (N = 550) or other animals (N = 14) with melioidosis, or from the environment
(N = 17), and originated from northeast and east Thailand (N = 524), Laos (N = 12), Cambodia
(N = 14), Hong Kong (N = 4) and Australia (N = 27). A single isolate was used from each
patient, animal or environmental source. The other bacterial species were: Acinetobacter bau-
mannii, Enterobacter aerogenes NCTC 10006, E. cloacae, Enterococcus faecalis ATCC 29212,
Escherichia coli, Haemophilus influenzae NCTC 11931, Hafnia alvei, Klebsiella oxytoca, K.
pneumoniae ATCC 700603, Morganella morganii, Neisseria gonorrhoeae, Proteus mirabilis,
Pseudomonas aeruginosa, P. putida, P. stutzeri, Salmonella enterica serovar Paratyphi A, S.
enterica serovar Paratyphi B NCTC 3176, S. enterica serovar Typhi NCTC 8385, Seratia mar-
cescens, Staphylococcus aureus ATCC 25923, Stenotrophomonas maltophilia, Streptococcus
pneumoniae ATCC 49619 and S. pyogenes. The original identification of B. pseudomallei was
performed by the submitting laboratories using a range of different methods that reflected var-
iation in clinical and research practice and the lack of a single gold standard method. In Asia,
MALDI-TOF MS for diagnosis of melioidosis
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the predominant method used was a combination of colony morphology, antibiotic suscepti-
bility pattern, arabinose assimilation and latex agglutination [35]. Elsewhere, colony appear-
ance followed by API20NE (bioMe´rieux) was commonly used. Other Burkholderia species
were identified using one or more of biochemical methods, including 16S rRNA sequence,
recA sequence and DNA-DNA hybridization [14–20]. Additional, non-Burkholderia species
were identified using standard laboratory methodology supplied by the Department of Medi-
cal Science, Ministry of Public Health, Thailand. All isolates were shipped in accordance with
international guidelines to an accredited BSL-3 laboratory in Bangkok where the evaluation
was conducted. Unless otherwise specified, bacteria were cultured on Columbia agar at 37˚C
Table 1. B. pseudomallei and other Burkholderia species used in this study.
Bacterial isolates (Total number) Source or strains Year of
isolationLocation Human Animal Environment
B. pseudomallei (N = 586) Reference strains (K96243, NR9921, 1106a, 1026b,
576a)
5 Varied
Sunpasitthiprasong Hospital, Ubon Ratchathani,
northeast Thailand
402 2012–2013
Ubon Ratchathani, northeast Thailand 27 14 1990–2001
Udon Thani Hospital, northeast Thailand 35 2015–2016
Khon Kaen Hospital, Khon Kaen, northeast Thailand 19 2015–2016
Nakhon Phanom Hospital, northeast Thailand 19 2015–2016
Buddhasothorn Hospital, Chachoengsao, east
Thailand
8 2014
Australia 14 10 3 2002
Cambodia 14 2006–2008
Lao PDR 12 2003–2005
Hong Kong 4 1987 and
2007
B. mallei (N = 21) Mongolia (Mongolia1, Mongolia2) 2 1960
Turkey (NH insan, Beygir CAU, Uludag) 6 1970–1984
India (NCTC 3708, NCTC 3709) 2 1931–1932
China (NCTC 10245, ATCC 23344, EY2233, EY2235,
EY2236, EY2237, EY2238 and EY2239)
8 1942–1951
Hungary (NCTC 10229, NCTC 10230) 2 1970–1984
Unknown (EY100) 1 Unknown
B. thailandensis (N = 4) Thailand (E175, E264, E421, E426) 4 1991–2001
B. thailandensis variants with B. pseudomallei-
like capsular polysaccharide (N = 6)
Thailand (SBXCC001, SBXCC005a, SBXCB001,
SBXPL007a, SBXPR001)
5 2014–2015
Cambodia (E555) 1 2005
B. cepacia (N = 8) Thailand (U668, 10223, NCTC 10744, MI1035) 4 Unknown
Thailand (2.1B, SBCAU015) 2 Unknown
Lao PDR (39628) 1 Unknown
Lao PDR (LNT40) 1 Unknown
B. humptydooensis (N = 1) Australia (MSMB43) 1 Unknown
B. oklahomensis (N = 3) Oklahoma, USA (c6786) 1 1973
Oklahoma, USA (c7532, c7533) 2 1973
B. multivorans (N = 1) UK (LMG16660) 1 Unknown
B. vietnamiensis (N = 1) Vietnam (LMG6999) 1 Unknown
B. ubonensis (N = 1) Thailand (DMST866) 1 Unknown
https://doi.org/10.1371/journal.pone.0175294.t001
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in air for 24 h. All isolates were stored in trypticase soy broth (TSB) with 15% glycerol at
-80˚C.
Latex agglutination test and multilocus sequence typing
Latex agglutination reagent based on the 4B11 monoclonal antibody to capsular polysaccha-
ride of B. pseudomallei was prepared and the assay performed as previously described [11, 35].
Multilocus sequence type (ST) was known for 21 B. pseudomallei, 21 B. mallei and 10 B. thai-
landensis isolates, which have been reported previously [13, 36, 37].
MALDI-TOF MS analysis
Protein was extracted from bacteria using the formic acid extraction method as previously
described [38, 39], with several modifications. In brief, a loopful of bacteria was harvested
from an agar plate and suspended in 300 μl ultra-pure distilled water (UDW), to which 900 μl
absolute ethanol (Merck, Darmstadt, Germany) was added. The suspension was centrifuged at
16,200 g for 2 min and the pellet left to dry at room temperature. Twenty-five microliters of
70% formic acid (V/V) (Sigma-Aldrich, Fluka, MO, USA) was added and mixed thoroughly,
followed by an equal volume of acetonitrile (Merck, Darmstadt, Germany). The mixture was
centrifuged at 16,200 g for 2 min, and then 1 μl of supernatant was spotted onto a MSP-384
polished steel target plate (Bruker Daltonics, Germany). After drying in air, all spots were over-
laid with 1 μl of matrix, α-cyano-4-hydroxycinnamic acid (HCCA) (Bruker Daltonics, Ger-
many) dissolved in a solution of 50% acetonitrile, 2.5% trifluoroacetic acid and 47.5% water
(Sigma-Aldrich, Fluka, MO, USA). Each spot was measured in 200 shot steps for a total of
1200 laser shots using an MALDI-TOF Mass Spectrometer Autoflex speed (Bruker Daltonics,
Germany) and FlexControl software (version 3.4.135, Bruker Daltonics, Germany). Spectra
were obtained in the linear positive mode with an accelerating voltage of 19.5 kV and analyzed
within a mass range of 2,000–20,000 Da. Before measurement, the instrument was calibrated
using the Bacterial Test Standard (BTS) following the manufacturer’s instructions (Bruker Dal-
tonics, Germany). E. coli DH5-Alpha was used as a positive control and matrix solution was
used as a negative control. Identification was achieved using the MALDI-Biotyper software
(version 3.1, Bruker Daltonics, Germany). These experiments were performed in duplicate
and the scores were averaged. Interpretation was performed according to the manufacturer’s
recommendation; score of 2.3, reliable species level identification; 2.0–2.29, probable species
level identification; 1.7–1.9, probable genus level identification; 1.7, unreliable identification
[40]. In a pilot study, at least 4 colonies (size ~ 1 mm) were required for B. pseudomallei to be
identified with a score of 2.3.
MALDI-TOF MS reference database
The Bruker Daltonics database (version 3.3.1.0) was expanded by adding main spectrum pro-
files (MSP) for 26 isolates after adjusting the baseline and smoothness using Flexanalysis soft-
ware (version 3.4, Bruker Daltonics, Germany). Twenty spots of a single protein extract from
each isolate were used to construct the MSP using the MALDI-Biotyper software (version 3.1).
The isolates used were as follows: B. pseudomallei (K96243, H2660a, H2708a, 1106a and
1026b), B. cepacia (LNT40, 10223, 2.1B, 39628, MI1035, NCTC 10744, SBCAU015 and U668),
B. humptydooensis (MSMB43), B. mallei (NCTC 10247 and Mongolia 1), B. multivorans
(LMG16660), B. oklahomensis (c6786, c7532 and c7533), B. thailandensis (E175, E264, E421
and E426), B. ubonensis (DMST866) and B. vietnamiensis (LMG6999). The five B. pseudomallei
isolates were selected as these have been used extensively as reference isolates, and whole
genome sequence and sequence type (ST) data are available (K96243, ST10; H2660a, ST 54;
MALDI-TOF MS for diagnosis of melioidosis
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H2708a, ST60; 1106a, ST70; and 1026b, ST102). These STs also represent the major B. pseudo-
mallei STs in Thailand [37]. B. mallei evolved from a single lineage of B. pseudomallei and the
two isolates selected here (NCTC 10247 and Mongolia 1) were used previously as reference
isolates is a study that described the discrimination between B. mallei and B. pseudomallei [25].
B. ubonensis, B. oklahomensis, B. humptydooensis and B. vietnamiensis are rarely described and
all isolates belonging to these species in our collection were used. B. cepacia, B. multivorans
and B. thailandensis were added since they may be misidentified as B. pseudomallei by some
identification systems.
Identification of specific peaks for the discrimination of Burkholderia
species
The Clinprotools software (version 3, Bruker Daltonics, Germany) was used to identify peaks
that discriminated between Burkholderia species. This was performed using 20 replicates of a
single protein preparation from each of nine Burkholderia species and B. thailandensis with
Bp-like CPS: B. multivorans LMG16660, B. ubonensis DMST866, B. vietnamiensis LMG6999,
B. cepacia NCTC 10744, B. oklahomensis c7533, B. thailandensis E264, B. thailandensis (Bp-like
CPS) E555, B. humptydooensis MSMB43, B. pseudomallei K96243, and B. mallei NCTC 3708.
Three independent experiments (20 replicates for each experiment) were performed and the
results of each experiment checked for consistency of the discriminating peaks.
The statistical algorithms incorporated in the Clinprotools software (Quick Classifier (QC)/
Different Average, Supervised Neural Network (SNN) and the Genetic Algorithm (GA)) were
used to analyze protein peaks between 2,000 and 20,000 Da. Potentially discriminatory peaks
were identified based on high reliable prediction and separation based on cross validation val-
ues (>90%), as described previously [30]. Three statistical tests (Anderson-Darling (AD), t-
test/ANOVA (TTA), and Wilcoxon/Kruskal-Wallis (W/KW) are incorporated into Clinpro-
tools and were used to analyse intensity data. All discriminatory peaks that exhibited P-values
of<0.01 by any of these statistical test were further evaluated by eye [41] and validated with
the peaks of other isolates from the same species. Peaks that were unique to specific species or
statistically different in intensity and showed consistent results from three independent experi-
ments were considered as the discriminatory peaks. All Burkholderia isolates used the for iden-
tification of discriminating peaks were used for the construction of a dendrogram.
MALDI-TOF MS dendrogram
To construct the dendrogram, Flexanalysis software (version 3.4) was used to adjust the base-
line and smoothness of the spectra. Twenty spots of a single protein extract for each isolate
were used to construct the main spectrum profiles (MSP) using the MALDI-Biotyper software
(version 3.1). The following parameters were used: the Biotyper MSP creation standard
method was used, with a maximum mass error of each single spectrum of 2000, desired mass
error for the MSP of 200, desired peak frequency minimum of 25%, and maximum desired
peak number for the MSP of 70. The isolates used were: 21 B. pseudomallei (NR9921, 1710a,
1106a, 576a, 1026b, K96243, SBPTHE0359, H2659A, SBPTHE0024, H2660a, SBPTHE0411,
H2613a, SBPTHE0031, H2820a, SBPTHE0383, H2708a, H1248a, SBPTHE0358, H2677a,
H2689b, H2644a), 21 B. mallei (EY100, NCTC 10245, T1, T2, T3, EY2233, EY2235, EY2236,
EY2237, EY2238, EY2239, NCTC 10229, NCTC 10248, NCTC 3708, NCTC 10230, NCTC
10260, NCTC 3709, NCTC 10247, Mongolia1, Mongolia 2, ATCC 23344), 10 B. thailandensis
(E175, E264, E421, E426, E555, SBXPL007a, SBXCC006a, SBXCC001, SBXCB001,
SBXPR001), 1 B. humptydooensis MSMB43, 3 B. oklahomensis (c6786, c7532, c7533), 8 B. cepa-
cia (NCTC 10744, MI1035, LNT40, 2.1B, U668, 39628, 10223, SBCAU015), 1 B. vietnamiensis
MALDI-TOF MS for diagnosis of melioidosis
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LMG6999, 1 B. ubonensis DMST866 and 1 B. multivorans LMG16660. The basis for the choice
of B. pseudomallei isolates was the inclusion of commonly used reference isolates (K96243,
H2660a, H2708a, 1106a and 1026b) and a further 16 isolates each assigned to a different ST
(ST696, ST76, ST77, ST80, ST345, ST40, ST126, ST177, ST70, ST501, ST102, ST10, ST54 and
ST60 (Fig 1). B. thailandensis and B. thailandensis with BP-like CPS capsule were randomly
selected from our freezer archive. We included all of the B. mallei (N = 21), B. humptydooensis
MSMB43 (N = 1), B. oklahomensis (N = 3), B. cepacia (N = 8), B. vietnamiensis (N = 1), B. ubo-
nensis (N = 1) and B. multivorans (N = 1) in our collection. Cluster analysis was performed
based on comparison of MSP using the following setting parameters: the distance measure was
set to Spearman, the linkage was set to single, and score threshold value for a single organism
was set at 1000.
Determination of minimum bacterial input for accuracy of MALDI-TOF
The minimum number of bacteria in suspension and minimum number of colonies required
to achieve an accurate MALDI-TOF result were determined. To quantify the number of bacte-
ria, the experiment was performed using bacterial suspension. B. pseudomallei K96243 was
harvested from an overnight culture of Columbia agar, suspended in sterile saline, adjusted to
approximately 1 x 107 CFU/ml and then serially diluted from 1 x 107 CFU/ml to 10 CFU/ml.
Bacterial cells in 1ml of each dilution were harvested by centrifugation at 16,200 g for 2 min.
Protein was extracted from each pellet prior to MALDI-TOF analysis as above. The bacterial
count was confirmed using Columbia agar spread plates in triplicate and colony counts after
overnight incubation at 37˚C. To determine the minimum number of colonies required for
MALDI-TOF, between 1 and 10 colonies (size ~1 mm) of B. pseudomallei K96243 were har-
vested from Columbia agar plates using a loop, suspended in UDW and the protein extracted
from each. Extracts were analyzed in triplicate in both assays. Spectra with maximal absolute
peak intensities ranging from 103 to 104 arbitrary units were considered for evaluation [42,
43].
Effect of culture media
The effect of culture media was examined for five B. pseudomallei isolates (K96243, NR9921,
1106a, 1026b and 576a). Bacteria were streaked onto Ashdown agar, blood agar, Columbia
agar, chocolate agar, Luria-Bertani (LB) agar, MacConkey agar, Mueller-Hinton agar, trypti-
case soy agar and incubated at 37˚C in air for 24 hours and harvested using a 1 μl loop ( 10
colonies, size ~1 mm). Bacteria were suspended in 300 μl UDW and the protein extracted and
analyzed in triplicate using MALDI-TOF MS.
MALDI-TOF MS identification of B. pseudomallei in spiked blood culture
Three BACTEC Plus Aerobic/F bottles were each inoculated with 10 ml of whole blood drawn
from a single healthy volunteer. An overnight culture of B. pseudomallei K96243 was adjusted
to approximately 1 x 108 CFU/ml, serially diluted to a concentration of 100 CFU/ml, and
100 μl (10 CFU) inoculated into each bottle. The inoculum was confirmed using colony counts
on agar plates. Bottles were incubated at 37˚C with 200 rpm shaking. At 12, 16, 20 and 24 h
after incubation, one ml from each bottle was withdrawn for protein extraction using ammo-
nium 0.826% NH4Cl (W/V) as a lysis buffer, as described previously [44, 45] with modifica-
tions. Briefly, an equal volume of 0.826% NH4Cl was added to 1 ml of blood culture fluid,
mixed and centrifuged at 16,200 g for 2 min. The pellet was lysed twice as above before wash-
ing twice with 1 ml ultrapure distilled water and centrifuged as before. The supernatant was
discarded and the pellet used for protein extraction.
MALDI-TOF MS for diagnosis of melioidosis
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RecA sequencing
recA sequencing and phylogenetic analysis was performed as previously described [20]. The
isolates tested were B. pseudomallei (N = 6), B. mallei (N = 7), B. thailandensis (N = 2), B. thai-
landensis variant strains with Bp-like CPS (N = 1), B. ubonensis (N = 1), B. oklahomensis
(N = 1), B. vietnamiensis (N = 1), B. cepacia (N = 5), B. humptydooensis (N = 1) and B. multivor-
ans (N = 1). Genomic DNA was extracted and PCR amplification performed using BUR3,
BUR4 and BUR5 primers as previously described [20]. Products were visualized using aga-
rose-gel electrophoresis and purified using ExoSAP-IT PCR Product Cleanup (Affymetrix UK
Ltd., UK). Purified PCR products were sequenced by Macrogen Inc. (Korea). Nucleotide
sequence of B. thailandensis E555 was obtained from the NCBI database (accession no.
AECN01000010.1). All sequences were aligned and trimmed to a 348 bp region using Clustal
W using MEGA software version 7 [46]. A maximum likelihood tree was constructed using
the Nearest-Neighbor-Interchange (NNI) and Tamura-Nei model [47] using MEGA software
version 7.0.14 [46].
Ethical approval
The study was approved by Ethics Committee of the Faculty of Tropical Medicine, Mahidol
University (approval number MUTM 2016-034-01). The principal investigator’s blood was
Fig 1. Phylogenetic tree of protein profiles of B. pseudomallei and 8 other genetically related Burkholderia species. Distance is displayed in
relative units. Annotated with MLST sequence type (ST) where known; each color represents a ST. The latex agglutination test was based on a
monoclonal that recognizes B. pseudomallei capsular polysaccharide.
https://doi.org/10.1371/journal.pone.0175294.g001
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used and verbal consent was obtained to participate in this study. The Ethics Committee of the
Faculty of Tropical Medicine, Mahidol University approved the procedure.
Results
Evaluation of MALDI-TOF MS for the identification of B. pseudomallei
Twenty replicates of B. pseudomallei K96243 were tested using MALDI-TOF MS and the Bru-
ker Daltonics database version 3.3.1.0. These were all identified as B. thailandensis, with a
median score below that for reliable species identification (median 1.96, range, 1.83–2.04). We
noted that the Biotyper database did not contain B. pseudomallei, B. mallei, B. ubonensis, B.
oklahomensis or B. humptydooensis, although did contain representation for 30 Burkholderia
species (B. ambifaria (N = 2), B. andropogonis (N = 1), B. anthina (N = 2), B. caledonica
(N = 1), B. caribensis (N = 1), B. cenocepacia (N = 2), B. cepacia (N = 9), B. diffusa (N = 1), B.
dolosa (N = 1), B. fungorum (N = 1), B. gladioli (N = 5), B. glathei (N = 1), B. glumae (N = 1), B.
lata (N = 1), B. latens (N = 1), B. metallica (N = 1), B. multivorans (N = 5), B. phenazinium
(N = 1), B. phymatum (N = 1), B. plantarii (N = 1), B. pyrrocinia (N = 2), B. sacchari (N = 1), B.
seminalis (N = 2), B. stabilis (N = 2), B. terricola (N = 1), B. tropica (N = 1), B. tuberum (N = 1),
B. thailandensis (N = 1), B. vietnamiensis (N = 1) and B. xenovorans (N = 1)). We extended the
database by adding reference profiles for B. pseudomallei (N = 5), B. mallei (N = 2), B. ubonen-
sis (N = 1) B. oklahomensis (N = 3) and B. humptydooensis (N = 1), together with further exam-
ples of B. cepacia (N = 8), B. thailandensis (N = 4), B. multivorans (N = 1), and B. vietnamiensis
(N = 1). We then tested the accuracy of MALDI-TOF MS for the identification of geographi-
cally and genetically diverse B. pseudomallei isolates. A large collection of 564 clinical and 17
environmental isolates from different locations in Thailand, and from Laos, Cambodia, Hong
Kong and Australia was tested. MALDI-TOF identified all 581 B. pseudomallei isolates cor-
rectly (100% sensitivity), with a median score for all isolates of 2.49 (range 2.30–2.68, IQR,
2.43–2.54) and no misidentification at the species level (Table 2). B. pseudomallei isolates
showed some variability in similarity scores against the 5 B. pseudomallei added here to the ref-
erence profiles. Despite this, the highest score was to B. pseudomallei for all 581 B. pseudomallei
tested, with the second and third highest score being B. mallei (median score 2.21, range 1.68–
2.46, IQR 2.14–2.29) and B. thailandensis (median score 2.01, range 1.62–2.22, IQR 1.95–2.06).
The specificity of MALDI-TOF MS was evaluated by testing 25 isolates including B. mallei
(N = 19), B. thailandensis (N = 6), and 23 isolates belonging to 21 species in other Genera (see
Methods). These bacterial species were correctly identified, indicating 100% specificity.
Effect of culture media on MALDI-TOF MS identification
We evaluated whether the culture medium used to grow bacteria prior to MALDI-TOF MS
affected the accuracy of identification. Five B. pseudomallei strains (NR9921, 1106a, 576a,
K96243, 1026b) were grown overnight on eight different solid media. All isolate/media combi-
nations were identified as B. pseudomallei, with an identification score of at least 2.45. The
median scores (range) of five isolates were as follows: Ashdown agar, 2.59 (2.48–2.68); blood
agar, 2.66 (2.49–2.75); Columbia agar, 2.65 (2.59–2.69); chocolate agar, 2.64 (2.48–2.67);
Luria-Bertani (LB) agar, 2.65 (2.47–2.70); MacConkey agar, 2.59 (2.47–2.62); Mueller-Hinton
agar, 2.63 (2.45–2.65); and trypticase soy agar 2.62 (2.49–2.67).
Identification of B. pseudomallei in spiked blood culture
Since the speed of identification of B. pseudomallei from blood culture is crucial for patient
management, we tested whether MALDI-TOF MS would give an accurate identification of B.
MALDI-TOF MS for diagnosis of melioidosis
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pseudomallei K96243 in spiked blood culture fluid. For this we used three 30 ml BACTEC Plus
Aerobic/F blood culture bottles each containing 10ml of blood from a healthy volunteer,
spiked with 10 CFU, and tested after 8, 10, 12 and 24 h of incubation at 37˚C with shaking.
Testing at 8, 10, 12 h showed unidentified or misidentified results, but accurate identification
for B. pseudomallei was obtained at the 24 h time point (median identification score 2.25
(range 2.17–2.36)). Colony counting demonstrated that the bacterial concentration in the
blood culture bottle fluid at 24 h was 2.1 x 109 CFU/ml.
Latex agglutination test
The latex agglutination test is used to rapidly identify B. pseudomallei colonies in our labora-
tory and elsewhere, and so we performed a comparative assessment of this versus MALDI-TOF
MS. The isolates used were 21 B. pseudomallei, 21 B. mallei, 10 B. thailandensis, 3 B. oklahomen-
sis, 8 B. cepacia, 1 B. vietnamiensis, 1 B. ubonensis and 1 B. multivorans. All B. pseudomallei
were positive by latex agglutination (Fig 1), as well as all B. thailandensis variants expressing
Bp-like CPS, some strains of B. mallei (14/21, 66.7%), and three strains of B. cepacia (LNT40,
39628 and 10223) which had previously given false-positive results (D. Dance, personal
communication).
Identification of discriminatory peaks
Twenty discriminatory peaks were identified from MSP spectra of representative isolates from
9 Burkholderia species and B. thailandensis with Bp-like CPS with cross validation results rang-
ing between 98% and 100% (Fig 2 and S1 Table). Three peaks (around 2,600 Da, 4,414 Da and
5,200 Da) were observed for all nine Burkholderia species. Peaks that were unique to specific
species were also observed, for example 2,908 Da for B. ubonensis, 3,932 Da for B. vietnamien-
sis, and 5,835 Da for B. thailandensis with Bp-like CPS. The only difference between B. thailan-
densis and B. thailandensis with Bp-like CPS was a peak of 5,835 Da. Compared to other
Burkholderia species, peaks with highest intensity that were statistically different (P< 0.001)
and useful to differentiate species were 2,049 Da for B. humptydooensis, 5,797 for B. pseudomal-
lei, 7,558 Da for B. mallei and 7,859 Da for B. vietnamiensis. We checked these peaks with
other isolates [B. pseudomallei (N = 21), B. mallei (N = 21), B. thailandensis (N = 4), B. thailan-
densis with Bp-like CPS (N = 6), B. oklahomensis (N = 3), B. cepacia (N = 8)] and found them
to be reproducible in other isolates of the same species.
Table 2. MALDI-TOF scores of B. pseudomallei from different geographical origins.
Locations No. of isolates tested Range Median IQR
Northeast Thailand Ubon Rachathani 443 2.30–2.68 2.51 2.45–2.55
Udon Thani 35 2.32–2.52 2.43 2.38–2.46
Khon Kaen 19 2.34–2.50 2.40 2.37–2.44
Nakhon Phanom 19 2.33–2.53 2.44 2.38–2.48
East Thailand Chachoengsao 8 2.34–2.49 2.39 2.35–2.42
Laos 12 2.46–2.66 2.52 2.48–2.60
Cambodia 14 2.35–2.57 2.47 2.44–2.50
Hong Kong 4 2.56–2.58 2.56 2.56–2.57
Australia 27 2.32–2.58 2.42 2.38–2.44
All isolates 581 2.30–2.68 2.49 2.43–2.54
https://doi.org/10.1371/journal.pone.0175294.t002
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Phylogeny based on MALDI-TOF MS protein profiles and recA
A phylogenetic tree based on the MSP of 67 Burkholderia isolates divided nine species into two
major branches (Fig 1). The first contained B. multivorans, B. vietnamiensis, B. ubonensis and
B. cepacia, and the second contained B. thailandensis, B. oklahomensis, B. humptydooensis, B.
mallei and B. pseudomallei. B. pseudomallei and B. mallei resided in distinct lineages but were
more related to each other than to B. thailandensis. Sequence types had been defined previ-
ously for the B. mallei and B. pseudomallei isolates [36, 37] and are shown in Fig 1. B. mallei
isolates belonged to a single ST (ST40), while B. pseudomallei belonged to 8 different STs.
A phylogenetic tree based on recA sequence was compared with the MALDI-TOF dendro-
gram for 26 isolates representing nine Burkholderia species (Fig 3). This demonstrated a
broadly similar structure between the two, with distribution of the species between two major
divisions. A notable difference was that MS distinguished between B. pseudomallei and B. mal-
lei, while the recA tree did not.
Discussion
MALDI-TOF MS is increasingly used for bacterial identification in diagnostic microbiology
laboratories. This technology can reduce time of identification since bacteria are sampled
directly from bacterial colonies and the test takes around 30 minutes to perform. The rapid
microbiological diagnosis of melioidosis is essential because clinical features are non-specific,
empiric drug regimens are sub-optimal, and infection is often fatal without appropriate
Fig 2. MALDI-TOF mass protein spectra of B. pseudomallei and 8 other genetically related
Burkholderia species. The vertical axis shows relative intensities of ions and the horizontal axis shows mass
to charge ratio (m/z) or masses of ions (Da).
https://doi.org/10.1371/journal.pone.0175294.g002
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treatment. This is compounded by the fact that healthcare providers in non-endemic countries
may not readily recognize melioidosis. MALDI-TOF MS could also be used for environmental
surveys looking at the distribution and presence of B. pseudomallei and related species.
Our findings confirm that MALDI-TOF MS can accurately identify B. pseudomallei regard-
less of geographic origin, and was able to reliably distinguish between this, other Burkholderia
spp. and a range of other common pathogens, provided that the database is suitably modified.
Since the top hit identification for each tested B. pseudomallei isolates could be any of five B.
pseudomallei isolates in our reference database, we recommended laboratories that wish to
identify B. pseudomallei using this method to extend the database by adding reference profiles
of all five B. pseudomallei isolates. Diagnostic laboratories use a range of culture media, but
we demonstrated that this has no effect on the performance of the test. We also showed that
MALDI-TOF MS accurately identifies B. pseudomallei in blood cultures, which could reduce
the time taken to diagnostic confirmation and appropriate antimicrobial treatment. Our
results confirm a previous report in which MALDI-TOF was used to identify B. pseudomallei
from blood cultures from two septicemic patients in Australia [29]. The simulated blood cul-
ture experiment in which 10 CFU was used as the starting inoculum reflects the bacterial load
in blood during human infection, which has been reported previously to be a median count of
1.1 CFU/ml [48]. Our observation that identification of B. pseudomallei by MALDI-TOF was
not accurate until after an incubation period of 24 hours implies that in clinical practice, this
method will be effective on bottles that have flagged in an automated incubation system or
after 24 hours or more of incubation.
The Clinprotools software used to support the interpretation of MALDI-TOF MS identifies
species-specific peaks as the basis for species identification [30, 41, 49]. In agreement with pre-
vious studies [25, 30], we identified specific peaks at 4,410, 5,794, 6,551, 7,553 and 9,713 Da for
all B. pseudomallei isolates tested. We also observed specific peaks for B. ubonensis (2,908 Da),
B. vietnamiensis (3,932 Da) and B. thailandensis variants expressing Bp-like CPS (5,835 Da).
The peak at 2,049 Da may be used to differentiate between B. pseudomallei and B. mallei
because this was present in all B. pseudomallei isolates but not in any B. mallei isolates. We also
noted several peaks which displayed significantly higher peak intensities in specific species,
which may be useful for the discrimination of B. humptydooensis (2,049 Da), B. multivorans
Fig 3. Comparison of recA sequence dendrogram (A) and protein profile dendrogram (B) of B. pseudomallei and 8 other genetically related
Burkholderia species.
https://doi.org/10.1371/journal.pone.0175294.g003
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(3,686 Da), B. pseudomallei (5,797 Da), B. oklahomensis (6,589 and 7,901 Da) and B. vietna-
miensis (7,859 Da).
Latex agglutination is a sensitive screening test for suspected B. pseudomallei, but positive
latex agglutination results have been described previously for B. mallei, B. thailandensis with
Bp-like CPS, S. aureus [11, 35, 50] and some strains of B. cepacia (unpublished data), poten-
tially leading to confusion in diagnostic laboratories if used alone. This study shows that MAL-
DI-TOF MS can be used to reliably distinguish between these organisms. Furthermore, both
MSP and recA dendrograms confirmed that B. pseudomallei, B. mallei and B. thailandensis
were arranged in the same phylogenetic group.
In conclusion, MALDI-TOF MS is an accurate and discriminatory tool for the identifica-
tion of B. pseudomallei if sufficient MSPs are added in the Biotyper database. MALDI-TOF MS
could be used to increase the rapid detection of cases of melioidosis in the clinical setting, and
reduce time to appropriate antimicrobial therapy.
Supporting information
S1 Table. Differentiating peaks of nine Burkholderia species. Peaks were based on analysis
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